ATP2A2 and cardiac hypertrophy: These points support the hypothesis that in EB-exposed animals, SERCA2 downregulation leads to an increased intracellular calcium concentration, which activates the calcineurin-NFAT pathway and finally results in cardiac hypertrophy.